ArticleIEEE transactions on audio, speech, and language processing (2025)2026
An End-to-End Overview of Clinical Speech AI.
Article in IEEE transactions on audio, speech, and language processing (2025), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
There has been a surge of interest in the use of speech as a biomarker for a wide range of health conditions, based on the premise that neurological, mental or physical impairments affecting speech production can be objectively assessed by automated analysis. Recent advances in clinical speech artificial intelligence (AI) have applied supervised learning techniques, similar to those used in general-purpose speech technology applications, to support the diagnosis and monitoring of mental health, cognitive decline, and motor disorders. Although clinical speech AI offers significant promise as a scalable and low-burden tool for health assessment, it also presents unique challenges compared to other speech technology applications. These include the need for condition-specific speech elicitation tasks, limited and heterogeneous datasets, sensitive data collection protocols, diverse speech representation and modeling strategies, and uncertainty in ground-truth clinical labels. This overview synthesizes the emerging literature that addresses these challenges in the full clinical speech AI pipeline: from speech elicitation and recording to representation, model development, and deployment. We provide a practical review of the field, including the technical pipeline for clinical AI, the design of clinical speech tasks, data collection practices, traditional and clinically oriented speech representations, predictive modeling approaches, and ethical considerations. We also discuss open technical and translational challenges and outline future research directions. The goal is to equip researchers and algorithm developers with the knowledge needed to move clinical speech AI from experimental development to real-world clinical impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.